(MedPage Today) — A GLP-1 receptor agonist may help improve metabolic profiles for certain schizophrenia patients on antipsychotics, the randomized HISTORI trial indicated.
Among 154 schizophrenia patients with prediabetes and overweight or obesity…
Source link : https://www.medpagetoday.com/psychiatry/schizophrenia/117292
Author :
Publish date : 2025-09-03 18:49:00
Copyright for syndicated content belongs to the linked Source.
